Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Alveolar type II cells are main target of
hyperoxia
-induced lung injury. The authors investigated whether lysosomal protease,
cathepsin B
(CB), is activated in fetal alveolar type II cells in the transitional period from the canalicular to saccular stages during 65%-
hyperoxia
and whether CB is related to fetal alveolar type II cell (FATIIC) death secondary to
hyperoxia
. FATIICs were isolated from embryonic day 19 rats and exposed to 65%-oxygen for 24 h and 36 h. The cells exposed to room air were used as controls. Cell cytotoxicity was assessed by lactate dehydrogenase-release and flow cytometry, and apoptosis was analyzed by TUNEL assay and flow cytometry. CB activity was assessed by colorimetric assay, qRT-PCR and western blots. 65%-
hyperoxia
induced FATIIC death via necrosis and apoptosis. Interestingly, caspase-3 activities were not enhanced in FATIICs during 65%-
hyperoxia
, whereas CB activities were greatly increased during 65%-
hyperoxia
in a time-dependent manner, and similar findings were observed with qRT-PCR and western blots. In addition, the preincubation of CB inhibitor prior to 65%-
hyperoxia
reduced FATIIC death significantly. Our studies suggest that CB activation secondary to
hyperoxia
might have a relevant role in executing the cell death program in FATIICs during the acute stage of 65%-
hyperoxia
.
...
PMID:Cathepsin B is activated as an executive protease in fetal rat alveolar type II cells exposed to hyperoxia. 2141 91